InformedDNA is the largest and most experienced independent genetics services company in the United States. According to Oliver Wyman, “genomics will change the fabric of everyday life and will disrupt business models of payers, providers and pharma alike” with estimated spend on genetic testing growing at 12% annually, projected to reach $30 billion by 2026, InformedDNA is well positioned to capitalize on the need for genetics expertise throughout the healthcare ecosystem. InformedDNA currently offers a broad range of leading edge genetics advisory services to health plans, hospitals and health systems, and life sciences companies. Current services include genetic counseling, genetics benefits management, clinical trial support, and expert advisory services. The company is committed to delivering excellent service as evidenced by a Net Promoter Score north of 70 from patients and an overall Customer Satisfaction Score of 98.5%. InformedDNA employs the largest full-time staff of independent objective genetics specialists in the nation. Current company investors include TT Capital Partners, NovaQuest Capital Management, Frist Cressey Ventures, Anthem, and management. See more at https://informeddna.com.